Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary

Tatsuya Maruhashi1, Junko Soga1, Noritaka Fujimura1

  • 1Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Insights

Vascular function tests, including flow-mediated vasodilation (FMD) and brachial-ankle pulse wave velocity (baPWV), predict cardiovascular events in coronary artery disease patients. Combining FMD and baPWV enhances cardiovascular risk stratification.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Clinical Cardiology

Background:

  • The clinical utility of vascular function tests for managing patients with coronary artery disease (CAD) remains incompletely understood.
  • Assessing endothelial function and arterial stiffness is crucial for cardiovascular risk prediction.

Purpose of the Study:

  • To evaluate the predictive value of flow-mediated vasodilation (FMD) and brachial-ankle pulse wave velocity (baPWV) for future cardiovascular events in patients with established CAD.
  • To determine if combining FMD and baPWV improves cardiovascular risk stratification.

Main Methods:

  • A prospective, multicenter observational study involving 462 patients with CAD.
  • Measurement of FMD and baPWV in all participants.
  • Follow-up for primary outcomes: coronary events and a composite of coronary events, stroke, heart failure, and sudden death.

Main Results:

  • Higher FMD (≥7.1%) was significantly associated with a lower risk of both primary outcomes (HR 0.27-0.32).
  • Higher baPWV (≥1731 cm/s) was significantly associated with a higher risk of both primary outcomes (HR 1.86-2.19).
  • Stratification by combined FMD and baPWV levels revealed stepwise increases in risk for cardiovascular events.

Conclusions:

  • Both FMD and baPWV are significant predictors of cardiovascular events in patients with coronary artery disease.
  • The combined assessment of FMD and baPWV offers enhanced cardiovascular risk stratification beyond individual measures.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
500
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
289
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
399
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
387